Logo image
Se connecter
How can the World Health Organization’s International Classification of Diseases (ICD)-11 change the clinical management of anaphylaxis?
Article de revue   Avec comité de lecture

How can the World Health Organization’s International Classification of Diseases (ICD)-11 change the clinical management of anaphylaxis?

Luciana Kase Tanno, Pascal Demoly et Joint Allergy Acad
Expert review of clinical immunology, Vol.14(10), pp.783-786
03/10/2018
PMID: 30203998

Résumé

Immunology Life Sciences
Anaphylaxis is currently recognized as a severe, life-threatening systemic hypersensitivity reaction characterized by rapid onset and the potential to endanger life. Since anaphylaxis is characterized by rapidly developing life-threatening airway and/or breathing and/or circulation problems, the need of rapid management of this condition is well-known. Epinephrine (adrenaline), injected by the intramuscular route, is the medication of choice for the first-aid treatment of anaphylaxis.

Indicateurs

1 Consultations de la notice

Détails

Logo image